Target intelligence / Profile preview

Dietary and luminal proteins and peptides

Molecular classification
Other
01

Overview

Dietary and luminal proteins and peptides in the intestinal lumen represent a diverse group of macromolecules derived from food intake and endogenous secretions. These substances are essential for providing amino acids required for protein synthesis and metabolic processes throughout the body (Source: StatPearls). In the intestinal lumen, they undergo mechanical and chemical digestion, primarily through the action of gastric and pancreatic proteases such as pepsin, trypsin, and chymotrypsin (Source: NIH). Beyond their nutritional role, certain dietary proteins can act as triggers for immune-mediated diseases, most notably gluten in Celiac disease (Source: Mayo Clinic). They also serve as precursors to bioactive peptides that can influence satiety, glucose metabolism, and gut motility (Source: PubMed). Therapeutic strategies targeting this group often focus on enhancing their breakdown in patients with digestive enzyme deficiencies, such as exocrine pancreatic insufficiency (Source: StatPearls). Other interventions involve neutralizing specific immunogenic peptides to prevent inflammatory cascades in sensitive individuals. Additionally, the presence of these proteins can affect the pharmacokinetics of co-administered drugs, particularly those that are peptide-based.

Other names
Dietary proteinsLuminal peptidesGastrointestinal proteinsFood-derived peptidesIntestinal polypeptides
02

Mechanism of action

The primary mechanism of action involves the enzymatic hydrolysis of peptide bonds, which reduces complex proteins into smaller peptides and amino acids to facilitate absorption or eliminate immunogenic epitopes (Source: StatPearls). In some cases, pharmacological agents may act by sequestering these proteins or inhibiting the transporters responsible for their uptake (Source: PubMed).

03

Biological functions

Nutrient supplyImmune response modulationHormonal signaling inductionNitrogen balance maintenance
04

Disease associations

Exocrine pancreatic insufficiencyCeliac diseaseFood allergyProtein-losing enteropathyPhenylketonuria
05

Safety considerations

Malabsorption syndromesImmunogenicity of exogenous enzymesNutritional deficienciesProteolytic degradation of co-administered peptide drugs
06

Interacting drugs

Pancrelipase

3 more in the full profile.

07

Biomarkers

Fecal elastase-1Serum albuminAnti-tissue transglutaminase antibodiesPlasma amino acid levels

Beyond the preview

Go deeper on Dietary and luminal proteins and peptides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary and luminal proteins and peptides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call